Vigilare Wealth Management Kiniksa Pharmaceuticals, Ltd. Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$7.6 - $11.41 $172,672 - $259,235	-22,720 Closed	0 $0
Q1 2022 Apr 06, 2022	SELL	$9.3 - $12.37 $27,435 - $36,491	-2,950 Reduced 11.49%	22,720 $226,000
Q4 2021 Jan 07, 2022	BUY	$10.39 - $15.15 $22,546 - $32,875	2,170 Added 9.23%	25,670 $302,000
Q3 2021 Oct 19, 2021	BUY	$11.39 - $16.23 $53,533 - $76,281	4,700 Added 25.0%	23,500 $268,000
Q2 2021 Jul 16, 2021	BUY	$13.22 - $19.09 $105,165 - $151,860	7,955 Added 73.35%	18,800 $262,000

Q1 2021 Apr 29, 2021	BUY	$16.68 - $23.97 $180,894 - $259,954	10,845 New	10,845 $201,000

164

40.6M

186K

157K

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $636M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.